 Anika Therapeutics NASDAQ:ANIK was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research report issued to clients and investors on Monday, Zacks.com reports. According to Zacks, Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of ... 